Latest filing published 21 May 2026 for Enovis CORP. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Sharon L. Wienbar span 4 companies, the busiest being Enovis Corp, Resideo Technologies, Inc. and Everyday Health, Inc. Between 2 June 2016 and 19 May 2026, the trades on record add up to 55 filings.
No open-market sale appears; the market trades are 1 purchase worth €46k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 48 share grants and 4 option exercises.
The latest filing, published on 21 May 2026, reports a share grant in Enovis Corp. The latest purchase dates back some time: it was published 2,528 days ago, on 18 November 2019. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations